Dynamic Market Modeling

Dynamic Market Modeling (DMM) is a scientifically rigorous way to understand and quantify the uncertainty and competitive dynamics that plague product demand and revenue forecasts. DMM produces strategically useful market predictions that inform such business decisions as segmentation, pricing, positioning, candidate or indication selection, R&D prioritization, clinical development planning, or franchise strategy.

Things are moving faster all the time. The market model is getting much regular use as we do innumerable what-if scenarios. Very helpful...

Ted Snelgrove, Senior Director, Marketing, Genomic Health, Inc.

DMM relies on customized primary market research designed to complement and focus information from general-purpose, secondary market research. Rosa specializes in developing practical surveys and sampling plans to ensure meaningful primary data. Rosa also designs the small-scale qualitative studies and focus groups that are occasionally needed before full-scale DMM structuring.

A Rosa team with significant senior-staff involvement works in close collaboration with the client team. The joint team organizes a DMM project as a decision project to ensure that the necessary organizational alignment is achieved, the models are easily understood, and the results are actionable upon completion of the study.

Rosa’s leaders and consultants have conducted hundreds of DMM projects during the past three decades, and have pioneered many of DMM’s technical underpinnings. Their broad market modeling and business strategy experience spans industries ranging from pharmaceuticals, diagnostics, and managed-care organizations to information technology, consumer products, and telecommunications. This breadth and depth of experience gives them a unique perspective on the increasingly dynamic and competitive markets for medical products.

The combination of credible quantitative methods, Rosa’s senior-level project team, and a focus on specific business decisions yields greater insight than traditional conjoint analysis and revenue forecasting methods.

For more information, see the following:

To discuss how Rosa & Co might help your company, please contact:

Ron Beaver, PhD
Executive Vice President
services@rosapharma.com